// App-Quantinova.ai

P258 : Real-world secukinumab retention, response rates and adverse events in the treatment of PsA and axSpA

Researchers

Presenter

  • Alistair Tindell

Principal Investigators

  • Saira Batool

  • Andrew McGucken

  • Stefan Siebert

Medical Centers

  • Rheumatology, Greater Glasgow & Clyde NHS Trust, Glasgow, UNITED KINGDOM

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Axial spondyloarthritis

Biomarkers

  • N/A

Drug/Treatment

  • secukinumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved